
Bro $ENLV just reported $1.23B in profit. Definitely not something you see on this space every day. The Nasdaq-listed biotech quietly turned itself into one of the most interesting plays in crypto by loading up on RAIN, the token powering a fully decentralized prediction markets and options protocol on Arbitrum. They’ve built a hybrid model: advancing their clinical-stage longevity/immunotherapy work (Allocetra for age-related inflammation) while running a serious digital asset treasury strategy centered on RAIN. Observing from the sidelines, this feels like a unique way to bridge TradFi and crypto conviction. Anyone else watching $ENLV? 👀

